CIK 0000920148
- Large accelerated filer
LABCORP HOLDINGS INC.
Sign in to watch- Ticker
- LH
- Exchange
- NYSE
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 992588107
- Phone
- +1 336-229-1127
- Business address
- 358 S MAIN ST, BURLINGTON, NC, 27215
- Former names
- LABORATORY CORP OF AMERICA HOLDINGS, NATIONAL HEALTH LABORATORIES HOLDINGS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,241,708
- in 3 filings, $108K under 10b5-1 plans
Net −$1,241,708. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-02-11 | EISENBERG GLENN A Executive Vice President | Option exercise | +807 | 33,458 | ||
| 2025-02-11 | EISENBERG GLENN A Executive Vice President | Shares withheld for taxes | −213 | $245.14 | $52K | 33,245 |
| 2025-02-11 | EISENBERG GLENN A Executive Vice President | Option exercise · Restricted Stock Unit | −807 | 2,819 | ||
| 2025-02-11 | BERBERIAN LANCE EVP, Special Advisor, Strategy | Option exercise | +323 | 16,766 | ||
| 2025-02-11 | BERBERIAN LANCE EVP, Special Advisor, Strategy | Shares withheld for taxes | −86 | $245.14 | $21K | 16,680 |
| 2025-02-11 | BERBERIAN LANCE EVP, Special Advisor, Strategy | Option exercise · Restricted Stock Unit | −323 | 1,067 | ||
| 2025-02-11 | Caveney Brian J EVP, Pres of ED, CMO & CSO | Option exercise | +473 | 29,471.66 | ||
| 2025-02-11 | Caveney Brian J EVP, Pres of ED, CMO & CSO | Shares withheld for taxes | −136 | $245.14 | $33K | 29,335.66 |
| 2025-02-11 | Caveney Brian J EVP, Pres of ED, CMO & CSO | Grant or award · Non-qualified Stock Options | +6,700 | 6,700 | ||
| 2025-02-11 | Caveney Brian J EVP, Pres of ED, CMO & CSO | Grant or award · Restricted Stock Unit | +2,220 | 4,661 | ||
| 2025-02-11 | Caveney Brian J EVP, Pres of ED, CMO & CSO | Option exercise · Restricted Stock Unit | −473 | 4,188 | ||
| 2025-02-11 | van der Vaart Sandra D EVP, Chief Legal Officer | Option exercise | +323 | 3,570.54 | ||
| 2025-02-11 | van der Vaart Sandra D EVP, Chief Legal Officer | Shares withheld for taxes | −86 | $245.14 | $21K | 3,484.54 |
| 2025-02-11 | van der Vaart Sandra D EVP, Chief Legal Officer | Grant or award · Non-qualified Stock Options | +3,400 | 3,400 | ||
| 2025-02-11 | van der Vaart Sandra D EVP, Chief Legal Officer | Grant or award · Restricted Stock Unit | +1,130 | 2,580 | ||
| 2025-02-11 | van der Vaart Sandra D EVP, Chief Legal Officer | Option exercise · Restricted Stock Unit | −323 | 2,257 | ||
| 2025-02-11 | Schroeder Mark S EVP, Pres Diagnostics & COO | Option exercise | +473 | 6,530.14 | ||
| 2025-02-11 | Schroeder Mark S EVP, Pres Diagnostics & COO | Shares withheld for taxes | −134 | $245.14 | $33K | 6,396.14 |
| 2025-02-11 | Schroeder Mark S EVP, Pres Diagnostics & COO | Grant or award · Non-qualified Stock Options | +7,300 | 7,300 | ||
| 2025-02-11 | Schroeder Mark S EVP, Pres Diagnostics & COO | Grant or award · Restricted Stock Unit | +2,420 | 5,061 |
Page 17 of 28 · 545 trades